View all services

Mergers & Acquisitions

Millendo Therapeutics, Inc. Merge With Tempest Therapeutics, Inc.

Millendo Therapeutics (NASDAQ: MLND), a biopharmaceutical company, merged with Tempest Therapeutics, a biotechnology company, in a transaction valued at $30 million.

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here:

For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.